NEUROCRINE BIOSCIENCES INC (18)

Browse by Contract Category

Contracts

Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan, as amended (Filed With SEC on August 4, 2022)
Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on August 4, 2022)
Commercial Lease dated February 8, 2022, by and between the Company and Gemdale Aperture Phase I, LLC (Filed With SEC on May 4, 2022)
Collaboration and License Agreement dated November 22, 2021 between Heptares Therapeutics Limited and the Company (Filed With SEC on February 11, 2022)
License Agreement dated February 9, 2017 between BIAL- Portela & CA, S.A. and the Company (Filed With SEC on May 5, 2021)
Employment Agreement dated November 29, 2021 between the Company and Jude Onyia (Filed With SEC on August 4, 2022)
Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, and Form of Restricted Stock Unit Award Grant... (Filed With SEC on February 11, 2022)
First Supplemental Indenture, dated as of December 22, 2021, by and between the Company and U.S. Bank National Association, as Trustee (Filed With SEC on February 11, 2022)
Collaboration and License Agreement dated March 31, 2015 between Mitsubishi Tanabe Pharma Corporation and the Company (Filed With SEC on May 5, 2021)
First Amendment to Collaboration and License Agreement Dated August 31, 2011 between the Company and Abbott International Luxembourg S.a.r.l (Filed With SEC on May 5, 2021)
Collaboration Agreement dated June 15, 2010, by and between Abbott International Luxembourg S.a.r.l. and the Company as amended on August 31, 2011 (Filed With SEC on May 5, 2021)
Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, and Form of Restricted Stock Unit Award Grant... (Filed With SEC on August 3, 2020)
Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 3, 2020)
Employment Agreement dated November 3, 2014 between the Company and Kyle Gano (Filed With SEC on February 7, 2020)
Description of Common Stock of the Company (Filed With SEC on February 7, 2020)
Third Amendment to Amended and Restated Lease between the Company and Kilroy Realty, L.P. dated August 7, 2019 (Filed With SEC on November 4, 2019)
Employment Agreement dated January 8, 2018 between the Company and Eiry W. Roberts, M.D (Filed With SEC on July 29, 2019)
Amendment No. 1 to Collaboration and License Agreement dated June 14, 2019 between Voyager Therapeutics, Inc. and the Company (Filed With SEC on July 29, 2019)